← Open Payments lookup

VEDAVYASA BILIYAR: Open Payments

NPI 1609814748 · NASHVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,209 in 52 payments from 14 companies in 2025. Trend: 2023 $228 · 2024 $483 · 2025 $1,209

Food & beverage: $1,209
CompanyPaymentsAmount
Otsuka America Pharmaceutical, Inc.11$191
Neurocrine BioSciences, Inc.6$180
Teva Pharmaceuticals USA, Inc.7$150
E.R. Squibb & Sons, L.L.C.6$144
Axsome Therapeutics, Inc.4$112
Alkermes, Inc.4$97
Janssen Pharmaceuticals, Inc4$87
Vanda Pharmaceuticals Inc.2$77
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)2$49
Takeda Pharmaceuticals U.S.A., Inc.2$43

Products named: INGREZZA, COBENFY, REXULTI, Auvelity, AUSTEDO XR, FANAPT, ARISTADA, CAPLYTA.

Industry payments across TN — which companies pay providers there.